Experiences of Bromelain-Based Enzymatic Debridement (Nexobrid) in Burn Patients: A Clinical Report
Hong Sil Joo, Joo Hoen Choi
J Wound Manag Res. 2021;17(3):207-212. Published online 2021 Oct 27 DOI: https://doi.org/10.22467/jwmr.2021.01767
Citations to this article as recorded by 
Pharmacological Profile of FDA-Approved Orphan Drugs in the Year 2022
Parveen Kumar Goyal, Kavita Sangwan
Current Pharmacology Reports.2024; 10(2): 96. CrossRef
Bromelain‐based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long‐term outcomes
Yaron Shoham, Konstantinos Gasteratos, Adam J. Singer, Yuval Krieger, Eldad Silberstein, Jeremy Goverman
International Wound Journal.2023; 20(10): 4364. CrossRef
Enzymatic debridement of deep facial burns with Nexobrid™: the Queen Victoria Hospital experience
Alexandra MacKenzie, Maria Chicco, Baljit Dheansa
European Journal of Plastic Surgery.2023; 46(6): 1315. CrossRef